SINGAPORE and COPENHAGEN, Denmark, April 21, 2021 /PRNewswire/ — Novo Holdings as we speak introduced that it has joined the US$ 80 million Sequence C financing in Halodoc, an Indonesia-based healthtech platform, which was led by PT Astra Digital Internasional, a subsidiary of PT Astra Worldwide Tbk (Astra) and joined by current and new buyers together with Temasek, Telkomsel’s TMI, Acrew Diversify Capital Fund, Bangkok Financial institution, UOB Enterprise Administration, Singtel Innov8, BliBli, Allianz X, and Openspace Ventures. That is the primary funding by the Novo Holdings Asian life sciences workforce in Singapore following arrange in 2020.
Based in 2016, Halodoc is a digital healthcare platform that features a cellular app and web site permitting clients throughout Indonesia to have dwell consultations with greater than 20,000 licensed docs within the nation at any time no matter the place they’re. In 2020, the corporate launched an appointment service that connects over 2000 suppliers (hospitals, clinics, laboratories) to sufferers in over 180 cities throughout the nation. Halodoc’s confirmed monitor report, led the Ministry of Well being appointing it to assist roll out Indonesia’s nationwide vaccination program. Halodoc vaccinated over 50,000 residents throughout two islands within the first 23 days of the vaccination program, making it one of many nation’s main vaccination facilitators.
Dr Amit Kakar, Senior Associate, Head of Novo Holdings Asia, stated: “We’re more than happy to spend money on Halodoc alongside this stellar group of buyers. During the last yr, telehealth has been transformational for sufferers all through the world. We consider Halodoc is Indonesia’s foremost telehealth platform. We’re seeing quite a few thrilling life sciences and healthcare funding alternatives within the Asia area which have the potential to ship new therapies, entry to healthcare and dramatically enhance outcomes for sufferers. We consider Novo Holdings’ world monitor report of investing in life sciences and healthcare mixed with our long-term method, partnering mindset and leveraging our world experience will allow us to construct a powerful presence within the area.”
Jonathan Sudartha, Halodoc CEO, stated: “We’re more than happy that Novo Holdings, some of the skilled life sciences buyers globally, has invested in Halodoc. Halodoc has grown to be Indonesia’s main healthtech supplier. Right this moment, we offer over 20 million customers with handy and dependable healthcare providers month-to-month. We’re additionally proud to be on the forefront of Indonesia’s combat in opposition to COVID-19. The Halodoc expertise that powers our Appointment system pre-pandemic is now getting used to supply a protected and environment friendly affected person journey for COVID-19 testing and vaccinations. We’re excited to increase our imaginative and prescient, and we respect the continued help given to us by our buyers, business companions, and sufferers we serve throughout the nation.”
The funds shall be used to deepen Halodoc’s penetration in key healthcare verticals throughout Indonesia, bettering affected person experiences with technology-based options for the nation’s most urgent healthcare issues.
About Novo Holdings A/S
Novo Holdings is acknowledged as a world-leading life science investor with a give attention to creating long-term worth. As a life sciences investor, Novo Holdings offers seed and enterprise capital to development-stage corporations and takes important possession positions in development and well-established corporations. Novo Holdings additionally manages a broad portfolio of diversified monetary property. For extra data: https://www.novoholdings.dk/
Halodoc is an online-based built-in well being utility that gives full and dependable well being options to fulfill the customers’ well being wants. Halodoc utility is provided with three principal options, that are Well being Retailer a service that may assist customers in shopping for dietary supplements, nutritional vitamins and medicines together with physician’s prescription shortly, safely & comfortably from 4,000+ trusted pharmacy companions; Chat with Physician, a service that facilitates customers to instantly interacting with 20,000+ full docs picks by way of voice calls, video calls or chat; and Appointment, the place customers can e-book appointments with docs in 1,000+ accomplice hospitals, and schedule for stroll in or drive via COVID-19 Testing and Vaccinations.
Halodoc has acquired a number of Worldwide recognitions: In 2019 and 2020 Halodoc was listed because the one and solely healthtech startup from SEA in CB Insights’ Digital Well being 150; whereas in 2018, Halodoc acquired “The Most Revolutionary Begin Up” award from Galen Development Asia and hand-picked by Forbes Indonesia as its “Alternative Begin Up” for the yr.
SOURCE Novo Holdings